此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

潮气量挑战和肺复张机动 (TIDALREC):脉压变化或每搏量变化对液体反应的可靠性。 (TIDALEC)

2026年9月28日 更新者:University Hospital, Lille

术中血液动力学优化:通过监测脉冲压力的变化和收缩期射血量的变化,对潮气量挑战和肺复张机动的液体反应性的预测值。

In order to predict fluid responsiveness in the operating room and therefore benefit of performing fluid administration to improve patient's hemodynamic status, it will test two ventilation strategies : the Tidal Volume Challenge (VtC) and the Lung Recruitment Maneuver (LRM).

The objective is to determine whether the variation of 2 parameters such as pulse pression variation (PPV) and stroke volume variation (SVV) during these 2 strategies, allows to predict fluid responsiveness in the operating room for any heavy surgery. All patients will benefit from the 2 ventilation strategies then a fluid administration, called " fluid challenge ", will be performed to discriminate the true responders and others. The order of the ventilation strategies will be determined by randomization.

研究概览

研究类型

介入性

注册 (实际的)

160

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Lille、法国、59037
        • Hop Claude Huriez Chu Lille

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Patients scheduled for major abdominal, vascular or neurosurgery requiring invasive arterial monitoring of SVV and PPV with placement of a radial arterial catheter connected to the ProAQT® System.
  • Block duration > 2 hours.

Exclusion Criteria:

  • open thoracique surgery
  • history of supra ventricular arrhythmias
  • beta-blocking patient
  • BMI>30 kg.m-2 or <15 kg.min-2
  • right ventricular dysfunction
  • severe valvulopathies
  • intracardiac shunt
  • renal failure dialysis
  • patient's refusal

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:放映
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Group 1

Starting LRM (Lung Recruitment Maneuver)

The LRM is performed first for 30 seconds (an insufflation pressure of 30 cmH2O for 30 seconds is applied). After a free interval of 3 minutes, the VtC is done during 1 minute. For VtC, tidal volume is increased from 6 to 8 ml.kg-1 of predicted body weight. Finally, after a new free interval of 3 minutes, the fluid challenge (consisting in fluid administration of 250 ml of Ringer Lactate) is started for 10 minutes (in aim to determine which patients are responders). This sequence is repeated every 30 minutes (maximum four times).

实验性的:Group 2

Starting VtC (Tidal Volume Challenge)

The VtC is performed first for 1 minute. After a free interval of 3 minutes, the LRM is done for 30 seconds. Finally, after another free interval of 3 minutes, the fluid challenge is started for 10 minutes. This sequence is repe-tead every 30 minutes (maximum four times).

研究衡量的是什么?

主要结果指标

结果测量
大体时间
潮气量挑战 (VtC) 期间脉冲压力 (VPP) 变化的 ROC 曲线 (AUC) 下的面积。
大体时间:整个手术过程(平均长度预计在 3 到 5 小时之间)。在 30 分钟的序列中执行的测量在手术过程中可能会发生多次
整个手术过程(平均长度预计在 3 到 5 小时之间)。在 30 分钟的序列中执行的测量在手术过程中可能会发生多次

次要结果测量

结果测量
措施说明
大体时间
The area under the ROC (AUC) curve of VPP during the alveolar recruit-ment maneuver.
大体时间:throughout surgery (mean length expected between 3 and 5 hours). Measurements performed during sequences of 30 minutes that can occur several times during surgery

The AUCs are measured before and after each strategies. Afterwards, the measurement is done before and after the " fluid challenge " in each group. This sequence of measurements will be recorded every 30 minute

throughout surgery (mean length expected between 3 and 5 hours). Measurements performed during sequences of 30 minutes that can occur several times during surgery
The AUCs of the two techniques calculated above.
大体时间:throughout surgery (mean length expected between 3 and 5 hours). Measurements performed during sequences of 30 minutes that can occur several times during surgery

The AUCs are measured before and after each strategies. Afterwards, the measurement is done before and after the " fluid challenge " in each group. This sequence of measurements will be recorded every 30 minute

throughout surgery (mean length expected between 3 and 5 hours). Measurements performed during sequences of 30 minutes that can occur several times during surgery
The area under the ROC curve (AUC) of stroke volume variation (SVV) during the tidal volume challenge (VtC).
大体时间:throughout surgery (mean length expected between 3 and 5 hours). Measurements performed during sequences of 30 minutes that can occur several times during surgery

The AUCs are measured before and after each strategies. Afterwards, the measurement is done before and after the " fluid challenge " in each group. This sequence of measurements will be recorded every 30 minute

throughout surgery (mean length expected between 3 and 5 hours). Measurements performed during sequences of 30 minutes that can occur several times during surgery
The area under the ROC curve (AUC) of stroke volume variation (SVV) during the lung recruitment maneuver.
大体时间:throughout surgery (mean length expected between 3 and 5 hours). Measurements performed during sequences of 30 minutes that can occur several times during surgery

The AUCs are measured before and after each strategies. Afterwards, the measurement is done before and after the " fluid challenge " in each group. This sequence of measurements will be recorded every 30 minute

throughout surgery (mean length expected between 3 and 5 hours). Measurements performed during sequences of 30 minutes that can occur several times during surgery
Number of complications in pneumothorax
大体时间:1 day (at recovery room after surgery) and at day 2

Pneumothorax is detected on chest x-ray in recovery room and then on clinical examination at Day 2.

1 day (at recovery room after surgery) and at day 2

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Gilles Lebuffe, MD,PhD、University Hospital, Lille

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2020年11月15日

初级完成 (实际的)

2021年7月17日

研究完成 (实际的)

2021年7月17日

研究注册日期

首次提交

2020年8月26日

首先提交符合 QC 标准的

2020年8月31日

首次发布 (实际的)

2020年9月1日

研究记录更新

最后更新发布 (实际的)

2026年10月1日

上次提交的符合 QC 标准的更新

2026年9月28日

最后验证

2023年1月1日

更多信息

与本研究相关的术语

其他研究编号

  • 2019_71
  • 2020-A01460-39 (其他标识符:ID-RCB number,ANSM)

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅